JPRN-UMIN000002746已完成1 期
Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer - Personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
Department of Urology Kinki University School of Medicine0 个研究点目标入组 20 人开始时间: 2009年11月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Any of other cancers Infections (ex. HBV, HCV, HIV) Other serious disorders (ex. heart, lung, pulmonary, kidney, allergic diseases)
研究者
相似试验
已完成
不适用
A phase I trial of actively personalized peptide vaccinations plus immunomodulators in patients with newly diagnosed glioblastoma concurrent to first line temozolomide maintenance therapyNL-OMON44016immatics biotechnologies GmbH5
已完成
2 期
A phase 2 clinical trial of personalized peptide vaccination for castration-resistant prostate cancer (CRPC) patients with slight bone marrow suppressioJPRN-UMIN000019802Cancer Vaccine Center, Kurume University School of medicine35
招募中
1 期
Personalized neoantigen peptide vaccine for advanced solid canceradvanced-stage non-small cell lung cancer (NSCLC),colorectal cancer (CRC),pancreatic cancer and melanomaNeoantigen peptide vaccine,Immunotherapy,Metastatic cancerTCTR20191003001Chulalongkorn University35
已完成
1 期
A phase I trial of personalized peptide vaccination using long and short peptides in patients with metastatic cancer resistant to standard treatmentsMetastatic cancer resistant to standard treatmentsJPRN-UMIN000013029Kurume University Cancer Vaccine Center10
已完成
2 期
A phase II trial of personalized peptide vaccination for nine kinds of cancersProstate cancer, Urothelial cancer, Breast cancer, Lung cancer, Ovarian cancer, Gastric cancer, Colon cancer, Liver cancer, Pancreatic cancerJPRN-UMIN000029789Kurume University900